🇺🇸 FDA
Patent

US 7112332

Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides

granted A61KA61K2039/542A61K2039/543

Quick answer

US patent 7112332 (Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/542, A61K2039/543, A61K39/00, A61K39/0283